This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethris Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Heymut Omran - Innovator in Ciliopathy Treatment
Introduction
Heymut Omran is an inventor based in Münster, Germany. He is currently associated with Ethris GmbH, where he focuses on innovative solutions for medical challenges. Although he has not yet been granted any patents, his work in the field of ciliopathies is noteworthy.
Latest Patent Applications
Heymut Omran's latest patent application is titled "Treatment of Ciliopathies." This application presents a pharmaceutical composition that includes a polyribonucleotide aimed at treating ciliopathies in subjects suffering from this condition. The polyribonucleotide encodes a functional version of a protein whose defect is linked to the ciliopathy. The application emphasizes the administration of this composition to the respiratory system, particularly when the subject exhibits inflammation of the respiratory system. Additionally, the application outlines a method for analyzing the effect of a polyribonucleotide on ciliogenesis, focusing on proteins involved in or required for this process.
Conclusion
Heymut Omran is making significant strides in the treatment of ciliopathies through his innovative research and patent applications. His contributions to the field hold promise for future advancements in medical therapies.